Rutin mediated targeting of signaling machinery in cancer cells

Area of Science:

• Molecular oncology
• Cancer biology
• Biochemistry

Background:

• Cancer involves dysregulated signaling, gene inactivation, stem cell behavior, and microenvironment changes.
• Cancer cells evade apoptosis, proliferate uncontrollably, promote angiogenesis, and suppress immune surveillance.
• Understanding these mechanisms is crucial for developing effective cancer therapies.

Purpose of the Study:

• To provide a recent overview of molecular oncology progress.
• To emphasize rutin's modulation of intracellular signaling cascades.
• To highlight the role of single-cell proteomics in cancer research.

Main Methods:

• Review of in-vitro and in-vivo research on rutin's effects.
• Analysis of single-cell proteomics data.
• Integration of preclinical study findings.

Main Results:

• Rutin demonstrates modulation of various intracellular signaling pathways.
• Single-cell proteomics reveals activated pathways in therapy-resistant cancers.
• Potential biomarkers for cancer diagnosis and prognosis identified.

Conclusions:

• Rutin shows promise in modulating cancer signaling pathways.
• Single-cell proteomics enhances understanding of cancer resistance mechanisms.
• Preclinical data supports bridging basic and translational cancer research.